Sertraline Delays Relapse in Recently Abstinent Cocaine-Dependent Patients with Depressive Symptoms(1)

AIMS: Whether the selective serotonin reuptake inhibitor sertraline at 200 mg/day delays relapse in recently abstinent cocaine dependent individuals DESIGN: 12-week, double blind, placebo-controlled clinical trial with 2-week residential stay followed by 10-wk outpatient participation SETTING: Veter...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Oliveto, Alison, Poling, James, Mancino, Michael J., Williams, D. Keith, Thostenson, Jeff, Pruzinsky, Rhonda, Gonsai, Kishorchandra, Sofuoglu, Mehmet, Gonzalez, Gerardo, Tripathi, Shanti, Kosten, Thomas R.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3237722/
https://ncbi.nlm.nih.gov/pubmed/21707811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1360-0443.2011.03552.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires